Avidity NanoMedicines Receives $6,000,000 New Financing Round

  • Feed Type
  • Date
    10/8/2014
  • Company Name
    Avidity NanoMedicines
  • Mailing Address
    11119 North Torrey Pines Road La Jolla, CA 92037 USA
  • Company Description
    Avidity NanoMedicines is advancing a new class of drug candidates, antibody-siRNA complexes (ARCs™), which draw on the best features of both antibody-drug conjugates and nucleic acid-based medicines and which utilize nano-scale self-assembly to create a transformative approach to the treatment of cancer and other serious diseases.
  • Website
    http://www.aviditynano.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $6,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds from the financing will be used to advance new cancer therapies that utilize the company’s proprietary antibody-siRNA complex (ARC™) platform.
  • M&A Terms
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor

Trending on Xconomy